EP3551187
NINTEDANIB FOR USE IN METHODS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASES BY COADMINISTRATION WITH OLODATEROL
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
6.12.2017EP published:
17.2.2021EP application number:
17811550.7
EPO information:
European Patent Register
Max expiry date:
5.12.2037
Title:
NINTEDANIB FOR USE IN METHODS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASES BY COADMINISTRATION WITH OLODATEROL
Timeline
Today
6.12.2017EP application
17.2.2021EP Publication
Owner
Name:
Boehringer Ingelheim International GmbHAddress:
Binger Strasse 173, 55216 Ingelheim am Rhein, DE
Inventor
Name:
WOLLIN, StefanAddress:
55216 Ingelheim am Rhein, DE
Name:
WEX, EvaAddress:
55216 Ingelheim am Rhein, DE
Name:
HERRMANN, FranziskaAddress:
55216 Ingelheim am Rhein, DE
Priority
Number:
16203359Date:
12.12.2016Country:
EP
Classification
Categories:
A61K 31/496, A61K 31/538, A61P 11/00